DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20164112

A study to evaluate prescribing pattern and cost minimization analysis of antihistamines among patients of allergy

Ayesha Vaseem, Mazher Ali, Md. Mustafa Ali Khan

Abstract


Background: Allergy is a hypersensitivity disorder of the immune system of the human body. In this study we selected CMA, It evaluates the cost differences between two or more medication from one group and with a similar clinical effect and then determines the least costly alternative. This helps in making best possible decision ensuring the maximum available benefits from every penny spent to achieve reasonable value for money.

Methods: This prospective observational study was conducted to assess the prescribing pattern and cost minimization of antihistamines in patients of allergy in a tertiary care teaching hospital. 210 outpatient and inpatient prescriptions of patients coming to tertiary hospital during the period July 2015 to July 2016 were studied and the most commonly prescribed antihistamines identified and their cost different between branded and generic versions analysed.

Results: Most commonly prescribed antihistamine is cetrizine followed by levocetrizine and fexofenadine.   

Conclusions: This study demonstrated a significant price difference, ranging from 4% to 83.75% between the branded and generic version of given drugs. This in turn is leading to an increase in the cost of total treatment.


Keywords


Antihistamines, Cost minimization analysis, Prescribing pattern

Full Text:

PDF

References


McConnell, Thomas H. The nature of disease: Pathology for the health professions. Baltimore. Lippincott Williams and Wilkins. 2007:159.

Types of Allergic Diseases. NIAID. 2015:29.

Anonymous. All India Coordinated Project on Aeroallergens and Human Health Report. Ministry of Environment and Forests, New Delhi; 2000.

Chhabra SK, Gupta CK, Chhabra P, Rajpal S. Prevalence of bronchial asthma in schoolchildren in Delhi. J Asthma. 1998;35:291-6.

Grammatikos AP. The genetic and environmental basis of atopic diseases. Annals of Medicine. 2008;7:482-95.

Viswanathan R. Definition, incidence, aetiology and natural history of asthma. Indian J Chest Dis. 1964;6:108-24.

Jindal SK, Aggarwal AN, Gupta D, Agarwal R, Kumar R, Kaur T, et al. Indian study on epidemiology of asthma, respiratory symptoms and chronic bronchitis in adults (INSEARCH). Int J Tuberc Lung Dis. 2012;16:1270-7.

Townsend RJ. Post-marketing drug research and development. Ann Pharmacother. 1987;21:134-6.

Drummond M, Smith GT, Wells N. Economic Evaluation in the Development of Medicines. London: Office of Health Economics. 1988:33.

Newby D, Hill S. Use of pharmacoeconomics in prescribing research. Part 2: Cost-minimization analysis – when are two therapies equal? J. Clin. Pharm. Ther. 2003;28(2):145-50

Shankar PR, Subish P, Mishra P, Lalit M. Ambiguous pricing of Nepalese medicines. Journal of institute of medicine. 2006;28:35-38

Lal A, Sharma ML. A calm look at the cost of drugs in psychiatric practice. Indian J Psychiat. 1992;34(1):18-20.

Jan aushadhi. Available at: http:// janaushadhi.gov.in /about_jan_aushadhi.html. Accessed on 20 August 2016.

Current index of medical specialities. UBM Medica India Private Limited, Bangalore. 2016:133:492-7.

L.Ramesh. Economic evaluation of antibiotic prescriptions: a cost minimization analysis. J App Pharm Sci. 2013;3(06):160-3.